Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma
The overexpression of epidermal growth factor receptors (EGFRs) has been reported in various human tumors, including breast, gastric, lung, colorectal, and pancreatic cancers. Humanized anti-EGFR and anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibodies (mAbs) have been shown to...
Saved in:
Main Authors: | Nami Tateyama (Author), Hiroyuki Suzuki (Author), Tomokazu Ohishi (Author), Teizo Asano (Author), Tomohiro Tanaka (Author), Takuya Mizuno (Author), Takeo Yoshikawa (Author), Manabu Kawada (Author), Mika K. Kaneko (Author), Yukinari Kato (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
by: Oh F, et al.
Published: (2018) -
T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
by: Daisuke Kamakura, et al.
Published: (2021) -
eIg-based bispecific T-cell engagers targeting EGFR: Format matters
by: Lennart Kühl, et al.
Published: (2023) -
Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1
by: Nishant Mohan, et al.
Published: (2022) -
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
by: Hogendoorn Pancras CW, et al.
Published: (2011)